64x Bio logo

64x Bio

Website
Current Valuation
N/A
As of April 29, 2025
Total Funding Raised
$59.5M
Last Round
Accelerator/Incubator

Amount undisclosed

Last Funding
Apr 2025

Funding date

Capital Efficiency
N/A

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

64x Bio is currently valued at N/A as of April 29, 2025. The company has raised a total of $59.5M in funding.

Investment Perspective

64x Bio's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.

Track 64x Bio Valuation Updates

Get notified when 64x Bio raises new funding or valuation changes

Explore More Data
Detailed analysis for 64x Bio

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

What is 64x Bio Worth in 2025?

As of 2025, 64x Bio is valued at N/A, based on the company's Accelerator/Incubator funding round in April 29, 2025. This valuation positions 64x Bio as one of the leading private companies in the sector.

64x Bio Valuation History

64x Bio's funding history demonstrates steady growth and investor confidence.

How 64x Bio Valuation is Determined

Private company valuations like 64x Bio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:

  • Revenue growth and financial performance
  • Market opportunity and total addressable market (TAM)
  • Competitive positioning and market share
  • Management team strength and execution capability
  • Technology and intellectual property
  • Industry trends and investor sentiment

64x Bio Valuation FAQs

Is 64x Bio profitable?

64x Bio has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.

How does 64x Bio's valuation compare to competitors?

64x Bio is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.

When will 64x Bio IPO?

64x Bio has not announced plans for an initial public offering. Until an IPO, investors can access 64x Bio shares through secondary market platforms.